U.S. Food and Drug Administration
Following Final NAC Guidance and Marketplace Stabilization, NPA Withdraws FDA Lawsuit
After securing final guidance for N-Acetyl-Cysteine (NAC) through a citizen petition and lawsuit, the Natural Products Association (NPA) dismissed its case against the U.S. Food and Drug Administration (FDA), which preserves legal rights and standing should additional action be necessary. The guidance also initiates the process for export certificates for NAC, which was a primary ...
CRN Responds to Cholesterol Study That Compares Supplements to Prescription Drug
The Council for Responsible Nutrition (CRN) has responded to results of the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study. It was presented at the American Heart Association Scientific Sessions Nov. 6 and published in the Journal of the American College of Cardiology. SPORT, funded by AstraZeneca, the company that markets Rosuvastatin, compared the effect on low-density ...
CRN Reminds Public About World Vitamin D Day
Wednesday, Nov. 2 is World Vitamin D Day and the Council for Responsible Nutrition (CRN) is taking the opportunity to remind the public about the nutrient’s importance in overall health and quality of life. In the recent release of CRN Foundation’s Health Care Savings Report, there is an entire chapter outlining how regular consumption of ...
NPA to Hold Educational Webinar Today on Identity and GMPs
Following a flurry of over 150 confusing and often contradictory warning letters from the Food and Drug Administration (FDA) to industry in the past [year/several months], the Natural Products Association (NPA) announced that it will host an interactive webinar providing insight, guidance, and educational support for the dietary supplement industry regarding identity within Good Manufacturing ...
CRN Disappointed, but Remains Committed to Product Listing for Dietary Supplements
On September 27, the Council for Responsible Nutrition (CRN) said it remains committed to its support of Mandatory Product Listing (MPL) despite the advancement of the drug user fee bill, the FDASLA Act of 2022, without including provisions to increase transparency for dietary supplements. In response to the release of the text of the Continuing ...
NPA Questions Why Dietary Supplements Aren’t Part of New FDA Criteria for “Healthy” Food Labeling
Days after the White House Conference on Hunger, Nutrition and Health, which convened on Wednesday, Sept. 28, for the first time in more than 50 years, concluded that nutrition was an essential part of an approach to health and wellness, the Natural Products Association (NPA) questioned why a proposed rule by the Food and Drug ...
NPA Urges California to Weigh Enforcement of Legislation Restricting Access to Dietary Supplements
On Sept. 8, following the passage of California’s AB 1341, which restricts access to dietary supplements and, in certain situations, requires a prescription to access these health products, the Natural Products Association (NPA) sent a letter to the California Department of Public Health Director Tomas J. Aragón urging the director to recognize the importance of ...
NPA to Hold Webinar “GMPs – Understanding and Mastering the Specification Requirements”
On Wednesday, September 14 at 1:30 EST, 10:30 AM PST, the Natural Products Association (NPA) will host an interactive webinar, providing insight, guidance and educational support for the dietary supplement industry regarding good manufacturing practices (cGMPs), 21 CFR Part 111. For dietary supplements, specifications are legally required to be established to ensure the identity, purity, ...
NPA Says California Bill Restricting Supplement Access Should Be Vetoed
On August 25, the Natural Products Association (NPA) called the passage of a California bill to restrict access to dietary supplements a slap in the face to public health and consumer choice. The California bill, AB 1341, restricts access to dietary supplements and in certain situations requires a prescription to access these health products. While ...
NPA, CRN Respond to Research Showing Supplements With Banned Ingredients are Still on the Market
A study recently published in JAMA by Pieter A. Cohen, MD; Bharathi Avula, PhD; and Kumar Katragunta, PhD, et al, has found that supplements with banned ingredients are still on the market despite the companies having received warning letters from the U.S. Food and Drug Administration (FDA). The study stated that “Some dietary supplements are adulterated ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!